Oegstgeest, The Netherlands, 20 April 2023 – ISA Pharmaceuticals, B.V., a clinical stage biotech company developing immunotherapies to treat cancers and infectious diseases, is pleased to announce that it will be participating and presenting in person, at the following scientific and business conferences in May and June of 2023. ISA’s versatile synthetic long peptide (SLP®) […]
BERLIN, 15 September 2022 – Ariceum Therapeutics (Ariceum), a private biotech company developing a radiopharmaceutical product for the diagnosis and systemic targeted radiation therapy of certain hard-to-treat cancers, today announces that its senior management team will be attending and hosting meetings at the following investor and scientific conferences in the fourth quarter of 2022. Read more…
22-23 MAR 2022 | DIGITAL
eTheRNA immunotherapies NV (‘eTheRNA’), a private clinical-stage biotechnology company developing mRNA-based immunotherapies for the treatment of cancer and infectious diseases, will be attending the following conferences from December 2021 to March 2022: BioFIT Digital 7-9 December 2021 Tim Van Assche, VP of Business Development and Alliance will be in attendance. ESMO Immuno-Oncology Online Congress 8-11 […]
